Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Appointed CFO
Quarterly results
CC transcript
VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/17/2015 SC 13G/A Ruane, Cunniff & Goldfarb reports a 10.2% stake in Valeant Pharmaceuticals Intl
02/10/2015 SC 13G/A BlackRock Inc. reports a 4.8% stake in VALEANT PHARMACEUTICALS INTERNATIONAL
02/02/2015 SC 13G/A BlackRock Inc. reports a 5.2% stake in VALEANT PHARMACEUTICALS INTERNATIONAL
02/14/2014 SC 13G/A Ruane, Cunniff & Goldfarb reports a 10.3% stake in Valeant Pharmaceuticals Intl
02/14/2013 SC 13G/A Ruane, Cunniff & Goldfarb reports a 11.4% stake in Valeant Pharmaceuticals Intl
02/14/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2011 SC 13G/A VALEANT PHARMACEUTICALS INTERNATIONAL reports a 3.6% stake in VALEANT PHARMACEUTICALS INTERNATIONAL
02/14/2011 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
01/25/2011 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
05/07/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/16/2010 SC 13G/A VALEANT PHARMACEUTICALS INTERNATIONAL reports a 7.9% stake in VALEANT PHARMACEUTICALS INTERNATIONAL
02/12/2010 SC 13G/A Clearbridge Advisors, LLC reports a 2.6% stake in Valeant Pharmaceuticals International Address of issuers principal executive offices: 1 Enterprise Aliso Viejo, CA 92656 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: Delaware Limited Liability Corporation Item 2d)
02/12/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/11/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
01/28/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
01/22/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/17/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
02/04/2009 SC 13G/A Iridian Asset Management reports a 11.9% stake in Valeant Pharmaceuticals International
01/16/2009 SC 13G/A J P MORGAN CHASE & CO reports a 0% stake in Valeant Pharmaceuticals International
01/15/2009 SC 13G/A FRANKLIN MUTUAL ADVISERS LLC reports a 6.3% stake in Valeant Pharmaceuticals International

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy